Hab Pharmaceuticals & Research is a finished-dose manufacturer based in India. It appears in 35 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by TMDA (TZ) and NAFDAC (NG). Customs aggregates show $22.0M of exports covering 762 molecules to 16 destinations in 2025.
| Site | FDA FEI |
|---|---|
| DEHRADUN, Tanzania | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 35 | 1 |
| TMDA (TZ) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $2.1M | 6 |
| 2025 | Not reported | $22.0M | 16 |
| 2024 | Not reported | $10.8M | 14 |
| 2023 | Not reported | $11.3M | 15 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Hab Pharmaceuticals & Research comes back tiered against every other supplier able to file there.
Start for free